What You Need to Know About BIA-ALCL Risks
If You Were Diagnosed with BIA-ALCL After Receiving Allergan BIOCELL Implants, You May Be Entitled to Significant Compensation.
For years, women across the country trusted Allergan textured breast implants for reconstructive and cosmetic surgeries. Many believed these implants were safe. Some were told they were more stable and more advanced than other options.
These women had no way of knowing these products would be linked to a rare and dangerous cancer known as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
BIA-ALCL is not breast cancer. It is a form of non-Hodgkin’s T-cell lymphoma that develops in the scar tissue and fluid surrounding a breast implant. Medical researchers now agree that this cancer is overwhelmingly associated with textured implants.
Among them, Allergan’s BIOCELL products have been identified as carrying the highest risk.
Despite years of warning signs, many women were not informed of this danger until after a global recall in 2019. Even now, new diagnoses continue to emerge, which is why The Yost Legal Group continues to accept clients who have been diagnosed with BIA-ALCL.
If you or a loved one has been diagnosed with BIA-ALCL after receiving Allergan textured breast implants, you may qualify to file an Allergan Biocell Lawsuit. You may be entitled to significant compensation under the growing multidistrict litigation. Call or text our experienced breast implant lawyers today for a free consultation: 410-659-6800.
In this latest Allergan litigation BIA ALCL blog post, we discuss how the cancer develops, why Allergan implants became the center of national litigation, and what women should know if they received textured breast implants.
Understanding your health is key to understanding your rights.
What You Need to Know About BIA-ALCL
Breast implant-associated anaplastic large cell lymphoma is a cancer of the immune system. It does not form in the breast itself. Instead, it develops within the fibrous capsule the body forms around a breast implant. This distinction between the two types of cancer is critical.
According to the American Society of Plastic Surgeons, BIA-ALCL is a rare type of non-Hodgkin’s lymphoma that has been found primarily in patients with textured surface breast implants.
This detail matters. The disease is not linked to whether the implant has a saline or silicone filling. It is linked to the implant’s textured surface.
In many cases, symptoms do not appear for years. The average time between implantation and diagnosis is often reported as seven to ten years. Because of this delay, many women do not connect their symptoms to one of the implants they received years ago.
Common warning signs of BIA-ALCL include:
Persistent swelling
Fluid accumulation
Breast or chest pain
Asymmetry
Lump in the breast or underarm
When caught early, BIA-ALCL may be treated surgically. When diagnosis is delayed, treatment can involve chemotherapy, radiation, or additional surgeries.
Why Textured Implants Pose a Higher Risk
Textured implants were designed to adhere more firmly to surrounding tissue. Manufacturers promoted them as less likely to shift and more anatomically stable, both of which may be true.
However, the rough surface created deep grooves that allowed bacteria and debris to collect. Over time, this environment can lead to chronic inflammation and immune system activation.
Researchers began noticing a pattern. Nearly all confirmed cases of BIA-ALCL involved textured implants. Smooth implants were rarely implicated.
As more global data emerged, Allergan’s BIOCELL implants repeatedly appeared at the center of reported cases. International regulators began to reach the same conclusion. These implants carried a significantly higher cancer risk than competing products.
The 2019 Allergan Breast Implant Recall
In July 2019, Allergan recalled its BIOCELL textured breast implants and tissue expanders worldwide following action by the United States Food and Drug Administration (FDA). By that point, regulators had been evaluating the connection between implants and lymphoma for nearly a decade.
The FDA first identified a potential association in 2011. Then, in 2016, the World Health Organization (WHO) formally recognized BIA-ALCL as a distinct disease entity.
Despite this history, many women were never warned of a cancer risk when they consented to surgery.
The recall did not require automatic implant removal. As a result, thousands of women continued living with recalled devices inside their bodies without clear guidance or long-term monitoring plans.
If you or a loved one was diagnosed with BIA-ALCL after receiving an Allergan textured breast implant, call the compassionate Allergan implant lawyers at The Yost Legal Group today. We will help you understand your rights and seek the justice you deserve. Call or text us for a free consultation: 410-659-6800.
BIA-ALCL: A (Years) Delayed Disease
One of the most troubling aspects of BIA-ALCL is its delayed onset. Women are often diagnosed many years after implantation. Some develop symptoms long after routine surgical follow-ups have ended. Others receive a diagnosis only after unexplained swelling or fluid buildup prompts further testing.
In some cases, BIA-ALCL has been diagnosed even after implants were removed.
This latency is one reason litigation remains active today. The recall did not end the danger. It simply confirmed that the danger existed.
The Federal Litigation Against Allergan
Claims involving Allergan BIOCELL textured breast implants have been consolidated in federal court in New Jersey under Multidistrict Litigation No. 2921.
As of early 2026, approximately 1,480 cases are pending in the federal MDL. That number continues to rise gradually as more women are diagnosed or undergo implant-related surgeries years after the recall.
These figures reflect federal cases only. Additional lawsuits are pending in state courts and are not included in the MDL total.
The continued growth of the litigation underscores an important point. BIA-ALCL is not a historical issue. It remains a present-day medical and legal crisis.
What the Allergan Implant Lawsuit Alleges
The lawsuits against Allergan focus primarily on failure to warn and defective design. Plaintiffs allege that the company knew or should have known that its textured implants carried a heightened cancer risk.
Despite mounting scientific evidence, Allergan continued to market these textured products as safe.
Women undergoing breast reconstruction or cosmetic surgery were not given meaningful information about lymphoma risk. Many say they would have chosen a different implant or declined surgery altogether if properly warned.
These cases are not about cosmetic dissatisfaction. They involve cancer diagnoses, invasive treatment, permanent scarring, emotional trauma, and long-term medical surveillance.
The Physical and Emotional Cost of the Defective Allergan Breast Implants
Treatment for BIA-ALCL frequently begins with the removal of the implant and the surrounding capsule. In advanced cases, lymph node removal, chemotherapy, or radiation may be required.
Medical expenses can be significant. Many women also lose income during treatment and recovery as they must take time off work or lose their jobs entirely.
Beyond the financial burden, survivors face fear, uncertainty, and the psychological impact of learning that a medical device placed in their body caused cancer.
For women who had previously survived breast cancer, this diagnosis can be especially devastating.
What Women With Allergan Textured Breast Implants Should Know
Women who received textured breast implants should not panic, but they should remain informed. Symptoms such as persistent swelling, late-onset fluid buildup, or unexplained breast changes should be evaluated by a medical professional familiar with BIA-ALCL.
A formal diagnosis is required for certain legal claims, but early evaluation can be critical to health outcomes.
Many women do not know which type of implant they received. Surgical records or a plastic surgeon’s office can often provide that information
However, if you think you may have received an Allergan textured breast implant, an experienced product liability attorney can help you request the medical records you require.
Legal Help for Women Harmed by Defective Breast Implants
Medical device manufacturers have a duty to warn patients of known risks. When that duty is breached, the consequences can be life-altering.
At The Yost Legal Group, our product liability lawyers represent individuals harmed by dangerous medical devices and pharmaceutical products. We understand the complexity of breast implant litigation and the medical science behind these cases.
If you or a loved one has been diagnosed with BIA-ALCL after undergoing surgery that involved recalled Allergan textured implants, you may have legal options. And we can help you understand your rights.
A conversation costs nothing. There are no upfront legal fees. Contact an experienced defective product lawyer to learn about filing a product liability claim. If you developed bia alcl due to a manufacturing defect or design defect, consulting a defective product law firm can help.
You deserved the truth before your surgery. If that truth was withheld, accountability matters. Call or text us today at 410-659-6800.
Allergan Lawsuit – Allergan Breast Implant Recall Attorney – BIA ALCL Lawsuit
Allergan Lawsuit Update – Allergan Breast Lawsuit – Product Injury Attorney
